Antimicrobial Susceptibility Testing Market 2021 - Impact of COVID-19, with the help of profile of major international groups, competitive landscape and key areas in 2027

The Antimicrobial Susceptibility Testing Market Report is a fusion of competitive scenarios and key trends affecting industry growth in areas of a successful business. In addition, a comprehensive survey of industry changes caused by the COVID-19 pandemic is also tagged in the report, helping investors and other participants make informed decisions. The report consists of a detailed study of potential segments, including product types, applications, end-users, and contributions to overall market size.

Top Key Players:

Accelerate Diagnostics, Becton, Dickinson Company, Biomerieux SA, Bio-Rad Laboratories, Bruker, Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche AG, HiMedia Laboratories, Merck KGaA (MilliporeSigma), Thermo Fisher Scientific.

Overview of the Antimicrobial Susceptibility Testing Market:

Antimicrobial susceptibility testing is the measurement of the resistance of different strains of bacteria to different antibiotics. This is important in the development of new and improved drugs since researchers are trying to develop and test more efficient and effective drugs against bacterial and viral infections and their symptoms. It is frequently used in the field of diagnostics as well because of its wide-ranging utility and ability to identify important factors that can contribute to the cause and development of infections. It is extensively used in many clinical settings, in research laboratories, and in health care settings where patients are prone to infection. There are various methods for testing for antimicrobial susceptibility. These include electrophoresis, broth microcentesis, expression in E. coli restriction enzymes, comparative analysis, and genetic analysis using various PCR-based methods including PCR amplicon technology, gene sequencing methodologies, and transcription-mediated amplification (TMA).

"We provide a sample of this report. Please see the following link to access the sample page containing TOC, key profiles, tables, and diagrams."

Request a sample report: https://www.stratagemmarketinsights.com/sample/43067

Market Drivers:

Growing prevalence of infectious disease epidemics such as Covid-19 is driving growth of the global antimicrobial susceptibility testing market. The test helps in the early diagnosis of the disease by determining a bacterium's, fungi's, or viral strain's susceptibility to a panel of antifungals, antibiotics, and antivirals. Moreover, rising awareness regarding antimicrobial susceptibility testing among medical practitioners is again fostering growth of the market. Rapid growth in the biopharmaceutical, biotechnological, and pharmaceutical companies is another major factor contributing to growth of the antimicrobial susceptibility testing market.

North America is expected to witness significant growth over the forecast period and this is attributed to the high prevalence of hospital-acquired infections (HAIs) in the region. According to the Centers for Disease Control and Prevention, in American hospitals alone, the Centers for Disease Control (CDC) estimates that HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year. Of these infections: 32 percent of all healthcare-acquired infections are urinary tract infections and 22 percent are surgical site infection

Key Developments:

• In January 2020, Sysmex Corporation has reached an agreement to invest in Astrego Diagnostics AB. Through this investment, Sysmex aims to help commercialize a rapid drug susceptibility test1 that Astrego is developing for urinary tract infections

• In July 2021, Accelerate Diagnostics, Inc. announced the launch of a new IVD configuration of its Accelerate PhenoTest® BC kit in the United States. With this launch, the Company now provides two solutions for fast sepsis testing. The new configuration provides fast antimicrobial susceptibility testing (AST) results in approximately 7 hours direct from positive blood cultures

The report covers segment analysis:

Based on Type, the Antimicrobial Susceptibility Testing market is segmented:

• Manual Products
• Consumables
• Automated Products

Based on the Application, the Antimicrobial Susceptibility Testing market is divided

• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Benefits of purchasing the Antimicrobial Susceptibility Testing Market Report:

Some of the key factors that companies are interested in have been specifically identified and studied. For example, market segmentation, revenue, Covid-19 impact, predictive analytics, key players, regional analytics, product types and applications, new innovation strategies and product introductions, and many other factors contribute to market growth. It is mentioned. Therefore, this report serves as a useful blueprint for your business.

We will highlight certain regions that hold higher profits compared to other regions and explain why they are responsible for this advantage.

The Antimicrobial Susceptibility Testing research report also describes the various drivers, opportunities, and constraints of the market. It also provides market-wide relevant information by assessing various factors to provide SWOT & PESTEL analysis. Overall information covering all market factors, aspects, scenarios, and situations in global standards can be found in the research report.

Main reasons to buy:

Gain a comprehensive understanding of the Global Antimicrobial Susceptibility Testing Market Industry Analysis and Forecast 2021-2027 and its commercial outlook with market insightful analysis. Learn about market strategies adopted by competitors and major organizations. Antimicrobial Susceptibility Testing Market Industry Analysis and Forecast Understand the future outlook and outlook for 2021-2027.

Need customization? Enter your requirements here: https://www.stratagemmarketinsights.com/quiry/43067

Contact Us:

Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737
Email: sales@stratagemmarketinsights.com
SJ

Who We Are:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. We strive to offer sapient solutions, expert consultations, and tailored/customized solutions. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports. The domain-specific teams are constantly focused on tracking markets, aiding our clients to gain a competitive edge through high-quality market intelligence. We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management.

This release was published on openPR.